Antitumor immunotherapeutic nanoagents enable molecular-photoswitching-based dynamic regulation of enzymatic activity of IDO1 for blocking immune evasion
- 23 September 2026
- journal article
- Published by Elsevier in Biomaterials
- Vol. 338 (Pt A) , 124657
Abstract
No abstract availableKeywords
Funding Information
- Major Science and Technology Project of Hainan Province (ZDYF2026SHFZ089)
- National Natural Science Foundation of China (22277120)
- National Natural Science Foundation of China (22461020)
This publication has 27 references indexed in Scilit:
- Multifunctional Polymeric Nanoparticles Codelivering Paclitaxel and Monoclonal Antibodies for Triple Combination Therapy of Colorectal CancerBiomacromolecules, 2025
- PD-L1 antibody conjugated dihydrotanshinone I-loaded polymeric nanoparticle for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell deathInternational Journal of Pharmaceutics, 2024
- Magnesium sensing via LFA-1 regulates CD8+ T cell effector functionCell, 2022
- Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppressionSeminars in Cancer Biology, 2020
- In Vivo PhotopharmacologyChemical Reviews, 2018
- Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA VirusesImmunity, 2018
- Substrate binding in human indoleamine 2,3-dioxygenase 1: A spectroscopic analysisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2017
- Emerging Targets in PhotopharmacologyAngewandte Chemie International Edition, 2016
- Photopharmacology: Beyond Proof of PrincipleJournal of the American Chemical Society, 2014
- Mechanism of Amide Formation by Carbodiimide for Bioconjugation in Aqueous MediaBioconjugate Chemistry, 1995